Your browser doesn't support javascript.
loading
Proximity proteomics identifies septins and PAK2 as decisive regulators of actomyosin-mediated expulsion of von Willebrand factor.
El-Mansi, Sammy; Robinson, Christopher L; Kostelnik, Katja B; McCormack, Jessica J; Mitchell, Tom P; Lobato-Márquez, Damián; Rajeeve, Vinothini; Cutillas, Pedro; Cutler, Daniel F; Mostowy, Serge; Nightingale, Thomas D.
Affiliation
  • El-Mansi S; Centre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Robinson CL; Centre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Kostelnik KB; Centre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • McCormack JJ; MRC Laboratory of Molecular Cell Biology, University College London, London, United Kingdom.
  • Mitchell TP; Centre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Lobato-Márquez D; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Rajeeve V; Cell Signalling & Proteomics Group, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Cutillas P; Cell Signalling & Proteomics Group, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Cutler DF; MRC Laboratory of Molecular Cell Biology, University College London, London, United Kingdom.
  • Mostowy S; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Nightingale TD; Centre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Blood ; 141(8): 930-944, 2023 02 23.
Article de En | MEDLINE | ID: mdl-36564030

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Actomyosine / Facteur de von Willebrand Type d'étude: Prognostic_studies Langue: En Journal: Blood Année: 2023 Type de document: Article Pays d'affiliation: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Actomyosine / Facteur de von Willebrand Type d'étude: Prognostic_studies Langue: En Journal: Blood Année: 2023 Type de document: Article Pays d'affiliation: Royaume-Uni